Our work aims to improve oncological care through translational and basic research into molecular causes of disease and biomarkers. We develop innovative therapies for gynaecological tumours, test new active substances preclinically and clinically, and research genetic changes. Through interdisciplinary networking, clinical studies at the University Tumour Centre and the JECTU/Jena Early Trial Unit, we strive to provide targeted, individualised treatment for our patients.

No Image